Carroll Investors, Inc
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1911400
Mt Pleasant, SC
Position in RXRX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,836,280
+$272,346 QoQ
Shares Held
500,349
-1.8% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#55
of 344 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Carroll Investors, Inc holds $1,836,280 across 1 Biotechnology name. RXRX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
500,349 | $1,836,280 |
All Filings in RXRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,836,280 | 500,349 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,563,934 | 509,425 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,656,188 | 404,936 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,935,900 | 396,701 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,951,146 | 385,602 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,805,640 | 341,331 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,669,618 | 246,985 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,072,456 | 162,740 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $605,745 | 80,766 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $137,576 | 13,799 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||